Survival and Complication Rates of Metastasectomy in Patients With Metastatic Renal Cell Carcinoma Treated Exclusively With Targeted Therapy: A Combined Population-based Analysis

Anticancer Research ◽

10.21873/anticanres.13604 ◽

2019 ◽

Vol 39 (8) ◽

pp. 4357-4361 ◽

Author(s):

CARLOTTA PALUMBO ◽

ANGELA PECORARO ◽

SOPHIE KNIPPER ◽

GIUSEPPE ROSIELLO ◽

ZHE TIAN ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Targeted Therapy ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Population Based ◽

Complication Rates

Download Full-text

Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study

The Lancet Oncology ◽

10.1016/s1470-2045(12)70285-1 ◽

2012 ◽

Vol 13 (9) ◽

pp. 927-935 ◽

Author(s):

Lauren C Harshman ◽

Wanling Xie ◽

Georg A Bjarnason ◽

Jennifer J Knox ◽

Mary MacKenzie ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Targeted Therapy ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Population Based ◽

Conditional Survival ◽

Population Based Study

Download Full-text

A Population-Based Overview of Sequences of Targeted Therapy in Metastatic Renal Cell Carcinoma

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2013.12.003 ◽

2014 ◽

Vol 12 (4) ◽

pp. e127-e131 ◽

Author(s):

Nimira Alimohamed ◽

Jae-Lyn Lee ◽

Sandy Srinivas ◽

Georg A. Bjarnason ◽

Jennifer J. Knox ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Targeted Therapy ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Population Based

Download Full-text

Commentary on “Conditional survival of patients with metastatic renal cell carcinoma treated with VEGF-targeted therapy: A population-based study.” Harshman LC, Xie W, Bjarnason GA, Knox JJ, MacKenzie M, Wood L, Srinivas S, Vaishampayan UN, Tan MH, Rha SY, Donskov F, Agarwal N, Kollmannsberger C, North S, Rini BI, Heng DY, Choueiri TK, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2012.11.006 ◽

2013 ◽

Vol 31 (1) ◽

pp. 127-128 ◽

Author(s):

Stephen Boorjian

Keyword(s):

Renal Cell Carcinoma ◽

Targeted Therapy ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Population Based ◽

Conditional Survival ◽

Stanford University ◽

Population Based Study ◽

School Of Medicine

Download Full-text

Real-world cost-effectiveness of targeted therapy in metastatic renal cell carcinoma in Sweden: a population-based retrospective analysis

Cancer Management and Research ◽

10.2147/cmar.s188849 ◽

2019 ◽

Vol Volume 11 ◽

pp. 1289-1297 ◽

Author(s):

Josefine Redig ◽

Johan Dalén ◽

Ulrika Harmenberg ◽

Magnus Lindskog ◽

Börje Ljungberg ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Targeted Therapy ◽

Cost Effectiveness ◽

Cell Carcinoma ◽

Retrospective Analysis ◽

Metastatic Renal Cell Carcinoma ◽

Population Based

Download Full-text

The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study

The Lancet Oncology ◽

10.1016/s1470-2045(14)71222-7 ◽

2015 ◽

Vol 16 (3) ◽

pp. 293-300 ◽

Author(s):

Jenny J Ko ◽

Wanling Xie ◽

Nils Kroeger ◽

Jae-lyun Lee ◽

Brian I Rini ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Targeted Therapy ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Population Based ◽

Population Based Study ◽

Prognostic Tool ◽

Previously Treated

Download Full-text

Faculty Opinions recommendation of Cabozantinib versus sunitinib as initial targeted therapy for patients with metastatic renal cell carcinoma of poor or intermediate risk: the alliance A031203 CABOSUN trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727316145.793548433 ◽

2018 ◽

Author(s):

Camilo Jimenez

Keyword(s):

Renal Cell Carcinoma ◽

Targeted Therapy ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Intermediate Risk

Download Full-text

Faculty Opinions recommendation of The value of cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.9841956.10548054 ◽

2011 ◽

Author(s):

Axel Bex

Keyword(s):

Renal Cell Carcinoma ◽

Targeted Therapy ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Cytoreductive Nephrectomy

Download Full-text

Therapeutic Drug Monitoring of Targeted Therapy in Metastatic Renal Cell Carcinoma

Protein and Peptide Letters ◽

10.2174/0929866525666180531073959 ◽

2018 ◽

Vol 25 (6) ◽

pp. 528-533

Author(s):

Dehua Liao ◽

Dangang Shangguan ◽

Dunwu Yao ◽

Qing Zhu ◽

Lizhi Cao ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Targeted Therapy ◽

Therapeutic Drug Monitoring ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Drug Monitoring ◽

Therapeutic Drug

Download Full-text

Prognosis of Japanese metastatic renal cell carcinoma patients in the targeted therapy era

International Journal of Clinical Oncology ◽

10.1007/s10147-021-01979-9 ◽

2021 ◽

Author(s):

Sei Naito ◽

Tomoyuki Kato ◽

Kazuyuki Numakura ◽

Shingo Hatakeyama ◽

Tomoyuki Koguchi ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Targeted Therapy ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Download Full-text

Impact of metastasectomy on prognosis in patients treated with targeted therapy for metastatic renal cell carcinoma

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-016-2217-1 ◽

2016 ◽

Vol 142 (11) ◽

pp. 2331-2338 ◽

Author(s):

Dalsan You ◽

Chunwoo Lee ◽

In Gab Jeong ◽

Cheryn Song ◽

Jae-Lyun Lee ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Targeted Therapy ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Download Full-text